Christopher A. Rossi

Christopher A. Rossi

Partner

Berwyn, PA
Phone: 610.640.7846    Fax: 610.640.7835

New York, NY
Phone: 212.808.2713    Fax: 212.286.9806

rossic@pepperlaw.com

Mr. Rossi’s representations include:

  • multiple private equity, venture capital and debt fund managers in connection with the formation, management and operation of their funds, including SBICs
  • multiple SBICs in connection with the divestiture by SBA of SBA’s preferred limited partnership interest to secondary buyers
  • the alternative investment group of a large NYSE-listed investment advisor in connection with the structuring and formation of multiple private equity funds, including a fund complex consisting of an evergreen series-based private partnership vehicle, a traditional private equity fund-of-funds and a hedge fund-of-funds, all targeting energy and natural resources
  • a health care–focused venture capital firm (including its SBIC) as its general counsel in a wide variety of fund formation, operational, investment and investor relations matters
  • a private equity fund in connection with its acquisition of a gold mining company pursuant to a Chapter 11 bankruptcy reorganization plan and subsequent investments
  • an SBIC in connection with its secondary sale of a portion of its interests in several portfolio companies in the health care and information technology space to another a U.K.-based investment fund
  • a private equity fund in connection with its acquisition of several portfolio companies in the promotional products business and in the automotive security and audio products industry
  • a group of selling shareholders in a management buyout of a large regional residential real estate brokerage business
  • a distributor of manufacturer-branded automotive accessory and high performance and speed products in connection with its sale to a private equity fund
  • a private equity fund in connection with its platform acquisition of a national franchisor of health and fitness clubs and the concurrent acquisition of several large regional franchises and subsequent add-on acquisitions
  • a management team in a leveraged recapitalization of various affiliated businesses located in more than 30 countries, which was financed by major European private equity and mezzanine funds and banks
  • a private equity fund in its acquisition of a manufacturer and distributor of rodent and pest control products, lawn and garden care products and wildlife and pet caring and control products
  • a private equity fund in its acquisition of an outsourced manufacturer and distributor of fragrance products, creams, lotions and other personal care products
  • a private equity fund in its sponsorship of a leveraged recapitalization of an engineering design firm and subsequent add-on acquisitions
  • a U.S. subsidiary of a large French electronics and defense company in connection with its acquisition of a Silicon Valley–based developer of software development tools
  • a U.K.-based consumer health products company in its acquisition and subsequent sale of a U.S.-based medical products company
  • a large publicly traded provider of dialysis services in connection with several acquisitions of regional service providers
  • a privately held company in its acquisition of the chemical management business of a large publicly traded company
  • a privately held U.S.-based monofilament manufacturer in connection with its acquisition of a German-based group of companies and subsequent separate dispositions of its U.S. and European businesses
  • a developer and manufacturer of compound semiconductor materials in various financing, licensing and distribution matters and in its merger with a U.K.-based competitor.

Data protection laws have changed, so we have revised our Privacy Policy.

CLOSE